MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 74 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,052,465 | -30.1% | 1,472,331 | 0.0% | 2.91% | -41.2% |
| Q2 2023 | $10,085,467 | -12.1% | 1,472,331 | 0.0% | 4.94% | -10.5% |
| Q1 2023 | $11,469,458 | +2.4% | 1,472,331 | 0.0% | 5.52% | -25.4% |
| Q4 2022 | $11,204,439 | -6.9% | 1,472,331 | 0.0% | 7.40% | -7.4% |
| Q3 2022 | $12,029,000 | -15.5% | 1,472,331 | 0.0% | 7.99% | -21.4% |
| Q2 2022 | $14,237,000 | -31.0% | 1,472,331 | 0.0% | 10.16% | -8.8% |
| Q1 2022 | $20,642,000 | -31.3% | 1,472,331 | 0.0% | 11.14% | +5.0% |
| Q4 2021 | $30,065,000 | -8.3% | 1,472,331 | 0.0% | 10.61% | +62.2% |
| Q3 2021 | $32,804,000 | -1.8% | 1,472,331 | 0.0% | 6.54% | +22.2% |
| Q2 2021 | $33,422,000 | – | 1,472,331 | – | 5.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $7,052,465 | 2.91% |
| NEA Management Company, LLC | 7,692,298 | $36,846,107 | 2.85% |
| Octagon Capital Advisors LP | 812,895 | $3,893,767 | 0.60% |
| Alphabet Inc. | 1,464,015 | $7,012,631 | 0.45% |
| Avoro Capital Advisors LLC | 4,535,000 | $21,722,650 | 0.34% |
| Casdin Capital, LLC | 510,882 | $2,447,125 | 0.27% |
| Baker Brothers Advisors | 4,916,095 | $23,548,095 | 0.14% |
| Corton Capital Inc. | 14,460 | $69,263 | 0.04% |
| ExodusPoint Capital Management, LP | 619,248 | $2,966 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 27,844 | $133,373 | 0.02% |